Depreciation, Depletion and Amortization in USD of Boundless Bio, Inc. from 2023 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Boundless Bio, Inc. quarterly/annual Depreciation, Depletion and Amortization history and change rate from 2023 to Q1 2025.
  • Boundless Bio, Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2025 was $317K, a 20.5% increase year-over-year.
  • Boundless Bio, Inc. annual Depreciation, Depletion and Amortization for 2024 was $1.09M, a 13.5% increase from 2023.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

Boundless Bio, Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $317K +$54K +20.5% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025
Q1 2024 $263K 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025

Boundless Bio, Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.09M +$129K +13.5% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025
2023 $957K 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.